AdvaMed has kicked off its Virtual MedTech Conference, which will explore value-based care, untapped markets for innovation, compliance, and lessons learned from COVID-19, among other key issues.
The first week of on-demand programming also includes FDA expert perspectives on a number of topics, including:
- Cybersecurity Threats: Premarket & Postmarket Strategies to Transform Medical Devices from Brittle to Resilient, featuring Dr. Suzanne Schwartz, Deputy Director Office of Strategic Partnerships & Technology Innovation, CDRH
- Bringing Innovative Devices to Market: FDA and Industry Perspectives, with Dr. Owen Faris, Principal Deputy Director, Office of Product Evaluation & Quality, CDRH
- How to Advance Diverse Inclusion in Clinical Studies: Driving Actionable Solutions, featuring RADM Richardae Araojo, Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity, FDA; and Dr. Michelle Tarver, Director, Patient Science and Engagement Program, Office of Strategic Partnerships and Technology Innovation, CDRH
Those who register for the Virtual MedTech Conference will also have access to on-demand sessions via a virtual conference platform, with new sessions released every week through October 7. In addition, a number of simulcast sessions will be available for viewing from October 5-7, with sessions available on-demand through late October.
View the latest agenda for the Virtual MedTech Conference. Partnering opened on Tuesday, September 8, so participants can view other users and begin requesting networking meetings. To register for the conference, visit here.
